Cargando…

Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer

BACKGROUND: PRKAA1 encodes α-subunit of 5-AMP-activated protein kinase (AMPK), which has been implicated in the pathogenesis of carcinoma of the stomach. Previous works have suggested that polymorphisms in the PRKAA1 may be associated with the risk of non-cardiac gastric cancer (NCGC), but whether P...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Minbin, Jiang, Baohu, He, Bangshun, Tang, Min, Wang, Ping, Chen, Li, Lu, Jianwei, Lu, Peihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156979/
https://www.ncbi.nlm.nih.gov/pubmed/30253744
http://dx.doi.org/10.1186/s12885-018-4818-3
_version_ 1783358191436824576
author Chen, Minbin
Jiang, Baohu
He, Bangshun
Tang, Min
Wang, Ping
Chen, Li
Lu, Jianwei
Lu, Peihua
author_facet Chen, Minbin
Jiang, Baohu
He, Bangshun
Tang, Min
Wang, Ping
Chen, Li
Lu, Jianwei
Lu, Peihua
author_sort Chen, Minbin
collection PubMed
description BACKGROUND: PRKAA1 encodes α-subunit of 5-AMP-activated protein kinase (AMPK), which has been implicated in the pathogenesis of carcinoma of the stomach. Previous works have suggested that polymorphisms in the PRKAA1 may be associated with the risk of non-cardiac gastric cancer (NCGC), but whether PRKAA1 polymorphisms are related to clinical pathologic characteristics of gastric cancer and its clinical outcome is largely unknown. METHODS: We carried out a case-control study including a total of 481 gastric cancer patients and 490 healthy controls. The genotypes of enrolled polymorphisms were identified with Sequenom MassARRAY platform. RESULTS: This study showed that rs10074991 GG genotype (adjusted OR = 1.44, 95%CI:0.99–2.09, p = 0.056) has a borderline significantly increased risk for gastric cancer, which was consistent with the result of additive model (adjusted OR = 1.21, 95%CI:1.01–1.46, p = 0.042). In similar, an increased risk of gastric cancer was also observed for rs13361707 TC genotype (adjusted OR = 1.47, 95%CI: 1.01–2.14, p = 0.043; additive model: adjusted OR = 1.22, 95%CI: 1.02–1.47, p = 0.033). Furthermore, the rs154268 and rs461404 were also found associated with increased gastric cancer risk, which may be influenced by age, tumor type and differentiation, and tumor stage. Haplotype analysis indicated A-G-C-T-C-G haplotype (rs6882903, rs10074991, rs13361707, rs3805490, rs154268 and rs461404) is associated with increased risk of gastric cancer (OR = 1.29, 95%CI: 1.02–1.62, p = 0.035). The univariate analysis for overall survival (OS) revealed that both of rs10074991 and rs13361707 variants are associated with poor OS in patients with NCGC. CONCLUSION: This case-control study provided the evidence thatrs13361707CC, rs10074991GG, rs461404GG, and rs154268CC are associated with increased gastric cancer risk, especially for NCGC, and that patients with rs10074991 G or rs13361707 C allele have a poor OS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4818-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6156979
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61569792018-09-27 Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer Chen, Minbin Jiang, Baohu He, Bangshun Tang, Min Wang, Ping Chen, Li Lu, Jianwei Lu, Peihua BMC Cancer Research Article BACKGROUND: PRKAA1 encodes α-subunit of 5-AMP-activated protein kinase (AMPK), which has been implicated in the pathogenesis of carcinoma of the stomach. Previous works have suggested that polymorphisms in the PRKAA1 may be associated with the risk of non-cardiac gastric cancer (NCGC), but whether PRKAA1 polymorphisms are related to clinical pathologic characteristics of gastric cancer and its clinical outcome is largely unknown. METHODS: We carried out a case-control study including a total of 481 gastric cancer patients and 490 healthy controls. The genotypes of enrolled polymorphisms were identified with Sequenom MassARRAY platform. RESULTS: This study showed that rs10074991 GG genotype (adjusted OR = 1.44, 95%CI:0.99–2.09, p = 0.056) has a borderline significantly increased risk for gastric cancer, which was consistent with the result of additive model (adjusted OR = 1.21, 95%CI:1.01–1.46, p = 0.042). In similar, an increased risk of gastric cancer was also observed for rs13361707 TC genotype (adjusted OR = 1.47, 95%CI: 1.01–2.14, p = 0.043; additive model: adjusted OR = 1.22, 95%CI: 1.02–1.47, p = 0.033). Furthermore, the rs154268 and rs461404 were also found associated with increased gastric cancer risk, which may be influenced by age, tumor type and differentiation, and tumor stage. Haplotype analysis indicated A-G-C-T-C-G haplotype (rs6882903, rs10074991, rs13361707, rs3805490, rs154268 and rs461404) is associated with increased risk of gastric cancer (OR = 1.29, 95%CI: 1.02–1.62, p = 0.035). The univariate analysis for overall survival (OS) revealed that both of rs10074991 and rs13361707 variants are associated with poor OS in patients with NCGC. CONCLUSION: This case-control study provided the evidence thatrs13361707CC, rs10074991GG, rs461404GG, and rs154268CC are associated with increased gastric cancer risk, especially for NCGC, and that patients with rs10074991 G or rs13361707 C allele have a poor OS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4818-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-25 /pmc/articles/PMC6156979/ /pubmed/30253744 http://dx.doi.org/10.1186/s12885-018-4818-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chen, Minbin
Jiang, Baohu
He, Bangshun
Tang, Min
Wang, Ping
Chen, Li
Lu, Jianwei
Lu, Peihua
Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title_full Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title_fullStr Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title_full_unstemmed Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title_short Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
title_sort genetic variations in prkaa1 predict the risk and progression of gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156979/
https://www.ncbi.nlm.nih.gov/pubmed/30253744
http://dx.doi.org/10.1186/s12885-018-4818-3
work_keys_str_mv AT chenminbin geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT jiangbaohu geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT hebangshun geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT tangmin geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT wangping geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT chenli geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT lujianwei geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer
AT lupeihua geneticvariationsinprkaa1predicttheriskandprogressionofgastriccancer